Market Chatter: Moderna, Other Vaccine Developer Stocks Rise as NIH Plans to Expedite Cancer Vaccines

MT newswire2026/10/09 14:57

10:57 AM EDT, 10/09/2026 (MT Newswires) -- Moderna (MRNA) and other vaccine developers were up on Friday after The New York Times reported that the National Institutes of Health is part of a public-private partnership to accelerate the development of cancer vaccines. Moderna shares were up 5.4% around 10:50 am ET, while shares of Merck (MRK) and Novavax (NVAX) were up 1.7% and 9.2%, respectively. Shares of BioNTech (BNTX), Vaxcyte (PCVX) and Vir Biotechnology (VIR) were up 2.5%, 5.7% and 3.1% (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 207.71, Change: +10.71, Percent Change: +5.44

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

SpaceX (SPCX.US) undergoes board changes: Google executive departs, Tesla merger evaluation underway.

SpaceX (SPCX.US) announced on Friday that Don Harrison has resigned from the company's board of directors.

智通财经•2026/11/07 06:31

The major cycle's downward structure remains intact, while the minor cycle's rebound lacks volume: Is this a support zone or just a consolidation phase?

AiCoin•2026/11/07 06:03

NEAR Price Falls 8.14% as Analyst Eyes Buys Below $3.50 Level

CoinCryptoNewz•2026/11/07 05:03

Goldman Sachs expects $7.5 billion in buying of gold and silver in January next year, while crude oil faces selling pressure of $7.9 billion.

金十数据•2026/11/07 03:47